Cargando…
Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells
PDAC (pancreatic ductal adenocarcinoma) is a highly aggressive malignant tumor. We have previously developed induced tumor-suppressing cells (iTSCs) that secrete a group of tumor-suppressing proteins. Here, we examined a unique procedure to identify anticancer peptides (ACPs), using trypsin-digested...
Autores principales: | Cui, Changpeng, Huo, Qingji, Xiong, Xue, Li, Kexin, Fishel, Melissa L., Li, Baiyan, Yokota, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610494/ https://www.ncbi.nlm.nih.gov/pubmed/37896207 http://dx.doi.org/10.3390/pharmaceutics15102447 |
Ejemplares similares
-
Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma
por: Li, Kexin, et al.
Publicado: (2023) -
The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes
por: Huo, Qingji, et al.
Publicado: (2023) -
Three unconventional maxims in the natural selection of cancer cells: Generation of induced tumor-suppressing cells (iTSCs)
por: Li, Kexin, et al.
Publicado: (2023) -
The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs)
por: Li, Kexin, et al.
Publicado: (2023) -
PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma
por: Zeleniak, Ann E., et al.
Publicado: (2017)